Rationale: Chronic obstructive pulmonary disease (COPD) has been identified as a risk factor for cardiovascular diseases such as myocardial infarction. The role of COPD in cerebrovascular disease is, however, less certain. Although earlier studies have suggested that the risk for stroke is also increased in COPD, more recent investigations have generated mixed results.
Large population-based studies have shown that CVD is not only a common cause of mortality in people with COPD, accounting for up to one-third of all deaths (3) , but also that the risk of cardiovascular mortality in this population is approximately twice that in the general population (4) . Although the underlying reasons are not yet fully understood, there is evidence to suggest that COPD is an independent risk factor for the development of cardiovascular disease, with systemic inflammation providing the mechanistic link between the two (5-7).
The relationship between COPD and individual CVD outcomes has been the subject of several reviews (8) (9) (10) (11) . Whereas collective evidence points to an approximately twofold increase in the risk of a myocardial infarction (MI) (8, 11) , the nature of the association between COPD and stroke is less certain. Earlier study findings are suggestive of an increased risk for stroke in people with COPD (12, 13) , but more recent investigations have generated contradictory results (14) . To clarify the role of COPD in relation to stroke, we performed a further systematic review of the available evidence linking COPD and stroke outcomes in which we report results separately for cross-sectional study designs (which estimate prevalence) and longitudinal cohort studies (which estimate incidence). In addition, we have been able to include a number of more recently published population-based studies that investigate, in more detail than before, stroke outcomes by subtype.
Methods

Protocol and Registration
In accordance with the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) guidelines (15) , study objectives, inclusion criteria, search strategies, and analysis methods were prespecified and documented in a protocol, which was registered with the International Prospective Register of Systematic Reviews in March 2016 (PROSPERO registration number: CRD42016035932) and published in the open literature (16) .
Study Objectives
Our primary objective was to quantify the magnitude of the association between COPD and stroke. Secondary objectives were to determine (1) whether there is any evidence that the association between COPD and stroke varies with age, sex, smoking history, and/or type of stroke (e.g., hemorrhagic vs. ischemic), and (2) whether stroke risk is modified in particular COPD phenotypes, for example, in frequent exacerbators.
Information Sources and Search Strategy
MEDLINE (OVID interface, 1948 onward) and EMBASE (OVID interface, 1980 onward) were searched in May 2016 for articles of potential relevance. Literature search strategies were developed using both Medical Subject Headings (MeSH) terms and free text searching, using an appropriate set of keywords to delimit the concepts "COPD" or "airflow limitation" and "stroke." These searches were combined using the AND Boolean logic operator. The database search was supplemented by a manual scan of the reference lists of included studies. The search strategies are detailed in Appendix E1 in the online supplement.
Eligibility Criteria
Inclusion criteria were drawn up using the PECOS (population, exposure, comparison, outcome, study design) framework. We included observational studies that (1) employed either a crosssectional, cohort, or case-control design; (2) were conducted in an adult population greater than 35 years of age; and (3) reported prevalence and/or incidence of cerebrovascular events (stroke) in people with a diagnosis of COPD or evidence of obstructed lung function (FEV 1 /FVC ratio, ,0.7) and also in a comparator group of individuals without COPD and/or with normal lung function. We also considered secondary analyses of randomized control trials where these met our other inclusion criteria. Accepted definitions for COPD included a physician diagnosis, recording of appropriate International Classification of Diseases (ICD)-9/ICD-10 codes in health care databases, spirometry, and self-report. We excluded abstracts, case histories, reviews, and commentaries. No language restrictions were applied.
Study Selection
Titles and abstracts of all records identified by the database searches were screened by two reviewers. Full texts were retrieved for all titles potentially meeting the predefined eligibility criteria. Full-text screening was also conducted by two reviewers. Discrepancies were resolved by discussion with a third reviewer. Information about study aims, design and setting, characteristics of the study population, COPD and stroke case ascertainment, as well as reported effect measures for the association between COPD and stroke outcomes were extracted for all included studies, using a predesigned form. Online supplementary material was consulted when necessary, and original authors were contacted to clarify and/or obtain numerical data as required.
Included studies were assessed for risk of bias, using a tool adapted from the Newcastle-Ottawa scale (17) by the investigators to suit the purposes of this review. The adapted tool (see Appendix E2) was structured around the three main sources of bias in our included studies: selection of participants, measurement of variables (exposures, outcomes, and covariates), and control of confounding. Each domain comprised several items, tailored where appropriate to take account of different study designs. Each item was assigned a risk of bias category as follows: "moderate-to-high risk of bias," "unclear risk of bias," or "low risk of bias." Risk of bias assessment was conducted independently by two reviewers on a subset of studies to check the internal validity and consistency of the tool.
Analysis Methods
The included studies were grouped according to study design to distinguish studies that estimated prevalence of stroke events in people with COPD versus people without COPD (as a simple percentage or as a prevalence odds ratio [POR]) from those using either a cohort or case-control design to calculate the incidence of stroke, again comparing COPD with COPD-free individuals (as an odds ratio [OR] , an incident rate ratio [IRR] , or a hazard ratio [HR]). We further grouped studies according to the study population characteristics (general population vs. secondary care), the nature of the quality of the exposure case definition (e.g., physician-diagnosed COPD vs. selfreported COPD), and the level of control for confounding (i.e., whether or not effect estimates had been adjusted for smoking). Several included studies reported multiple measures and/or conducted more than one type of analysis, and these are presented separately. The risk of bias assessment was also conducted separately for each analysis type.
Heterogeneity was assessed by means of the I 2 statistic. Given the high level of statistical heterogeneity, it was not deemed appropriate to calculate pooled effect estimates. A narrative synthesis was thus conducted.
Results
Study Selection and Characteristics
A total of 5,484 articles of potential interest were identified by the database searches ( Figure 1 ). After title and abstract screening, 305 articles, plus another 9 titles identified from reference lists of selected studies, were selected for full-text review. A total of 284 articles were subsequently rejected, leaving 30 studies to form the basis of this review. Table 1 (13, 14, summarizes the key characteristics of those studies that report prevalence measures and Table 2 (13, 14 , 23, 27, 37, 39, 41-45) those that estimate incidence. Fuller information is provided in the online supplement (Appendix E3).
Prevalence of Stroke Events
Twenty-five studies compared the frequency of stroke events in people with COPD with that in a comparator cohort of individuals without COPD (21 studies) or relative to a general or standard population (four studies), using a crosssectional study design; of these, 11 also reported crude or adjusted PORs ( Table 1) .
The majority of the included crosssectional studies indicated that stroke events are more prevalent in people with COPD than in the general population ( Figure 2 ). Only three studies (19, 34, 40) suggest otherwise. Of the 10 studies that reported prevalence ratios (PRs) in excess of 2, three were conducted in outpatient populations (18, 24, 32) and another two were based on self-reported diagnoses of both COPD and stroke (22, 25) . Of the 11 studies that also reported PORs, seven found significantly increased odds of a stroke event in people with COPD relative to those without ( Figure 3 SYSTEMATIC REVIEW 
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reported effect estimates adjusted for age and sex, only four adjusted for smoking ( Figure 3 ). The level of heterogeneity among studies reporting prevalence ratios was too great to justify reporting a pooled effect estimate (Figure 2) , even when studies were further stratified (see Appendix E4). However, heterogeneity was lower among the group of four studies that report PORs adjusted for smoking (I 2 = 45%), implying that smoking may be an important source of the observed heterogeneity. The pooled prevalence OR for this group of studies was estimated at 1.51 (95% CI, 1.09-2.09).
Risk of Incident Stroke
Eleven studies provided estimates of the relative risk of incident stroke in COPD (Table 2) ; of these, three reported IRRs, seven reported HRs, and two reported ORs (in which patients with a prior stroke history were excluded from the analysis). One study reported risk estimates for nonfatal and fatal stroke in the form of a standardized rate ratio (SRR for hospitalization) and a standardized mortality rate (SMR), respectively (41) . The majority of the older incidence studies reported effect estimates for any stroke event (a composite of ischemic, hemorrhagic, and "not specified" stroke); four estimated the relative risk of having a fatal stroke (23, 39, 41, 42) . One study reported results for ischemic strokes only (14) . Several of the more recently published large population-based cohort studies estimated relative risks by stroke subtype (43) (44) (45) . The effect of COPD disease severity was investigated in two studies (37, 44) .
Results of studies that estimated stroke risk in the form of IRRs or HRs are presented in Figure 4a , and those that reported either ORs or SRRs in Figure 4b , grouped according to whether effect estimates were adjusted for smoking. Collectively, these studies suggest an increased risk for incident stroke in people with COPD relative to those without. Effect estimates for all stroke ranged from 2.79 (95% CI, 2.56-3.04) to 1.11 (95% CI, 1.02-1.21), but the high degree of heterogeneity prohibited pooling of estimates (I 2 . 70%). Adjustment for smoking invariably reduced the strength of the association between COPD and stroke; among those studies that reported results unadjusted and adjusted for smoking, unadjusted effect estimates ranged from 1.20 SYSTEMATIC REVIEW the magnitude of the relative risk, but the effect estimates lost statistical significance. A number of studies reported effect estimates stratified by either age or sex, or both (13, 39, 45) . These analyses suggested that the effect of COPD on the risk of incident stroke is higher for women and in younger age groups (less than 65 yr). The study by Feary and colleagues (13) , for example, reported an adjusted HR for stroke of 3.44 (95% CI, 0.85-13.84) in subjects aged 35-44 years (the youngest age group) and a steady reduction in the relative risk for stroke with increasing age, down to 1.10 (95% CI, 0.98-1.23) among those over 75 years of age (Figure 4a) .
Three studies reported effect estimates by stroke subtype (43) (44) (45) . Two reported a greater relative risk for hemorrhagic stroke compared with ischemic stroke (Figure 5 ). Söderholm and colleagues found that the greatest risk was for subarachnoid hemorrhage (SAH) (HR SAH , 1.46; 95% CI, 1.16-1.85; HR ICH , 1.23; 95% CI, 1.16-1.43; HR IS , 1.20; 95% CI, 1.15-1.25), the risk for which did not diminish over the 10 years of follow-up, unlike that for ischemic stroke (IS) and intracerebral hemorrhagic (ICH) stroke, which was greatest during the initial 2-year period of follow-up (45) . In contrast, Lin and colleagues reported HRs for ischemic and hemorrhagic stroke of 1.64 (95% CI, 1.49-1.82) and 1.18 (95% CI, 0.89-1.57), respectively (43) .
None of our included studies found evidence of a relationship between COPD severity and stroke risk (37, 44) . Only Portegies and colleagues investigated the influence of exacerbation frequency on stroke risk and reported no difference in risk between frequent and infrequent exacerbators (44) . They did, however, observe a significantly increased risk for stroke in the 7-week period immediately after the onset of a severe acute exacerbation of COPD (adjusted HR, 6.6; 95% CI, 2.42-18.2). Figure 6 summarizes the results of the risk of bias assessment, displaying for each of the study design categories the proportion of analyses assessed as having a low risk of bias (green) and a moderate-to-high risk of bias (red). Results for individual studies are provided in the online supplement (see Appendix E5). Cross-sectional studies rated reasonably well in terms of the selection of the exposed and unexposed groups, but a relatively high proportion of studies relied on self-report and/or were unclear as to whether transient ischemic attacks were included in the definition of "any stroke." A significant number were conducted in hospital populations, involving smaller sample sizes and thus fewer stroke events. For the group of incidence studies, the main biases stemmed from the poor control of confounding, of smoking in particular, and the length of follow-up.
Risk of Bias Assessment
Discussion
This systematic review finds that strokes are more common in people with COPD than in the general population, and that the risk of experiencing an incident stroke is increased in people with COPD. Although the high level of heterogeneity limited our ability to quantify the magnitude of the increased risk of incident stroke, we suggest that this is relatively modest, and less than that reported for other cardiovascular outcomes such as MI.
The fact that the magnitude of the association between COPD and stroke is SYSTEMATIC REVIEW attenuated by adjustment for smoking implies that this shared risk factor accounts for much of the elevated risk, and that COPD by itself does not confer a large additional risk. Only two of the 11 analyses that estimated risk of incident stroke lend support to the hypothesis that COPD is an independent risk factor for stroke (13, 43) . We found evidence to suggest that the relative risk for stroke declines with increasing age, with the greatest risk occurring in those patients with COPD who are less than 65 years of age. There is also some evidence, albeit limited at the present time because of the paucity of studies, that the relative risk for hemorrhagic stroke may be greater than that for ischemic stroke (44, 45) . A heightened risk of hemorrhagic stroke, and SAH in particular, is consistent with reports of an increased presence of cerebral small-vessel disease in people with COPD, and implies a role for hypoxia and oxidative stress in the pathophysiology of stroke in COPD (46) (47) (48) . In this context, it is interesting to note that Arboix and colleagues, in their study of stroke registry patients, identified COPD as an independent risk factor for ischemic strokes of atherothrombotic origin (OR, 
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of ischemic stroke (e.g., lacunar and cardioembolic strokes) (49, 50) . Although this is consistent with the increased burden of carotid artery plagues of high lipid content seen in people with COPD (46), we are unable to corroborate this finding because of the lack of studies that examine ischemic stroke outcomes by subtype. We found no clear evidence that COPD severity influences stroke risk (independently of age). However, the role of exacerbations remains a matter of some debate and warrants further investigation. Two studies failed to find an association between exacerbation frequency and stroke risk (44, 51) , but others have reported markedly increased risks for stroke in the period immediately after an acute exacerbation relative to periods of more stable disease (44, 52) .
Our review serves to highlight several intriguing features of the evidence base linking COPD and stroke. The first is the differential in risk for MI and stroke in COPD (14) . Although a degree of heterogeneity in the magnitude of the associations between COPD and individual CVDs due to differences in the causal mechanisms that underpin the associations is to be expected (53), other factorssuch as competing risks-may well be contributing to the observed differential. It is also possible that treatment initiated for early cardiac disease may be preventing subsequent strokes in the COPD population (44) .
The second is the observation that whereas several population-based studies have demonstrated an inverse relationship between lung function impairment as measured by FEV 1 (% predicted) and stroke risk (54) (55) (56) (57) (58) (59) , few find evidence of a similar relationship with low FEV 1 /FVC, a measure that is indicative of airflow obstruction and thus COPD. For example, Hozawa and colleagues, using data from the Atherosclerosis Risk in Communities Study (ARIC), showed that nonsmoking white subjects with low FEV 1 (and FVC) were at increased risk of ischemic stroke; however, there was no evidence of an association with the FEV 1 /FVC ratio (56) . This finding highlights the need for more research to identify which aspects of impaired lung function are the most important in terms of CVD risks and to characterize the groups at greatest risk. The observed link between FEV 1 and vascular disease may, as some have suggested, imply a role for common early life determinants (60) . Alternatively, in terms of the development of vascular and airways disease, events in later life may be more relevant. Several studies have demonstrated increased risks for stroke in subjects with chronic bronchitis (61, 62) . This coupled with evidence of increased risk for stroke in the period after a severe exacerbation of COPD might imply that those with more bronchitic COPD, who experience frequent exacerbations and steeper rates of lung function decline, might be at heightened risk for ischemic stroke.
Strengths and Limitations
While the present review benefits from the adoption of a comprehensive search strategy and broad inclusion criteria, there are limitations. The main limitation is the high level of heterogeneity in the included studies, which precludes the calculation of an overall effect estimate. 
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The main sources of heterogeneity are differences in study population characteristics, coupled with variations in case definitions for both the exposure and outcomes. Studies sourcing individuals from secondary care are likely to have a higher proportion of patients with more severe disease and who are unlikely to be representative of the population of patients with COPD as a whole. Case definitions for COPD are highly heterogeneous, ranging from self-report to pulmonary physician diagnoses supported by spirometry. Misclassification of COPD with asthma is likely to represent a significant source of bias, even in studies that purport to use physician diagnoses. Although self-reported stroke diagnoses might be considered to be more reliable than those for COPD, studies are inconsistent in their definitions of all stroke and stroke subtypes.
The lack of adequate control for confounding, in particular smoking, represents another inherent limitation. Our review includes a number of studies that rely on administrative health care databases, the majority of which do not contain data on smoking. Given that many of our included studies investigated multiple CVD outcomes, not just stroke, we judge the risk of publication bias to be low.
Conclusion
Both prevalence and incidence of stroke are increased in people with COPD. The increased risk for incident stroke is attenuated by adjustment for smoking, suggesting that in the population as a whole COPD is not an independent risk factor for stroke. However, the possibility remains that COPD is a causal factor in certain subsets of patients with COPD, and for certain types of stroke. Our review highlights the need for further well-controlled and detailed longitudinal cohort studies to quantify the nature and magnitude of the risk of various stroke subtypes in people with COPD. n . Note: The signaling questions employed in the risk of bias assessment vary according to study type and are coded as follows: A1 relates to the representativeness of study population; A2 to the representativeness of exposed individuals; A3 to the representativeness/selection of unexposed individuals; B1 to the ascertainment of exposure; B2 to the assessment of the outcome; B3 to the length of followup (long enough for outcomes to occur); C1 to adjustment for confounding (appropriate); C2 to the sample size (adequate); C3 to the absence or otherwise of the outcome at study start; C4 to missing data (appropriate handling); and D1 to other potential sources of bias of concern. (See also Appendix E5.)
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